College of Medicine Celebrates 13 Nationally Recognized Medical Professors
On Wednesday, Jan. 6, the University of Cincinnati College of Medicine faculty and staff celebrated 13 medical professors who have been nationally recognized for being among the top 10 percent in their field. The event was hosted by William Ball, MD, College of Medicine dean and senior vice president for health affairs.
The following 13 UC College of Medicine professors received the Patient Experience Excellence Award:
- Michael Canos, MD Internal Medicine
- Stephen Dailey, MD Orthopaedic Surgery
- Andrew Duker, MD Neurology and Rehabilitation Medicine
- Hugh Gloster, MD Dermatology
- Adam Ingraffea, MD Dermatology
- Michael Holliday, MD Family and Community Medicine
- Bradley Mathis, MD Internal Medicine
- Caroline Mueller, MD Internal Medicine
- Sona Sharma, MD Internal Medicine
- Barbara Vinegar, DPM Surgery
- Abid Yaqub, MD Internal Medicine
- Nadia Yaqub, MD Internal Medicine
- Lee Zimmer, MD, PhD Otolaryngology-Head and Neck Surgery
The faculty members were selected for being among the top 10 percent of clinical providers in the Press Ganey national database. Press Ganey provides patient experience measurement and performance analytics for more than 22,000 health care facilities.
Related Stories
Certain weather patterns can trigger migraines
June 8, 2026
Certain weather patterns really do trigger migraine headaches — and the incidence is more common in the Midwest. As WGN 9 in Chicago recently reported, researchers at the University of Cincinnati College of Medicine have identified two specific weather patterns associated with an increased risk of headaches.
UC expert weighs in on current MASH treatment approaches
June 5, 2026
As MedCentral recently reported, pending broader pharmacologic approvals for metabolic dysfunction-associated steatohepatitis (MASH), lifestyle modifications remain the go-to intervention.
At least two weather patterns increase headaches, UC study suggests
June 4, 2026
University of Cincinnati physicians and collaborators identified two specific weather patterns that increase headache and migraine risk and found the preventive medication fremanezumab (Ajovy) can reduce weather‑associated headaches. The findings will be presented at the American Headache Society Annual Scientific Meeting in Orlando.